About ONO PHARMACEUTICAL
ONO PHARMACEUTICAL is a company based in Osaka (Japan) founded in 1947. ONO PHARMACEUTICAL has completed 1 acquisition, including Deciphera. ONO PHARMACEUTICAL operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Osaka, Japan
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ono Pharmaceutical Co., Ltd.
-
Annual Revenue
$3.26 B (USD)-3.14as on Mar 31, 2025
-
Net Profit
$334.93 M (USD)-60.89as on Mar 31, 2025
-
EBITDA
$604.15 M (USD)-50.32as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ONO PHARMACEUTICAL
ONO PHARMACEUTICAL is a publicly listed company on the TSE with ticker symbol 4528 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of ONO PHARMACEUTICAL
Unlock access to complete
Funding Insights of ONO PHARMACEUTICAL
Detailed funding history for ONO PHARMACEUTICAL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ONO PHARMACEUTICAL
ONO PHARMACEUTICAL has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Deciphera.
Investment portfolio details for ONO PHARMACEUTICAL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Type 2 kinase inhibitors for cancer treatment are developed.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for ONO PHARMACEUTICAL
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - ONO PHARMACEUTICAL
Detailed financials for ONO PHARMACEUTICAL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ono Pharmaceutical Comparisons
Peer comparison for ONO PHARMACEUTICAL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ONO PHARMACEUTICAL
ONO PHARMACEUTICAL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of ONO PHARMACEUTICAL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ono Pharmaceutical
Complete news archive for ONO PHARMACEUTICAL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ONO PHARMACEUTICAL
ONO PHARMACEUTICAL was founded in 1947.
ONO PHARMACEUTICAL is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Annual revenue of ONO PHARMACEUTICAL is $3.26B as on Mar 31, 2025.
ONO Pharmaceutical was established in 1947 in Osaka, Japan, as a research and development entity within the pharmaceutical sector. Operations center on the production of medications targeting various therapeutic areas, including immunology and oncology. Services encompass drug discovery, clinical trials, and global distribution, with headquarters maintained in Japan and international partnerships facilitated.
ONO PHARMACEUTICAL's top competitors include Merck, Roivant Sciences and AbbVie.
Yes, ONO PHARMACEUTICAL is publicly traded on TSE under the ticker symbol 4528.
ONO PHARMACEUTICAL has made 1 acquisition, including Deciphera.
The ticker symbol of ONO PHARMACEUTICAL is 4528 on TSE.